Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
COVID-19 vaccines
COVID-19 vaccines
Page 14 of 95
Tech
Facebook considers relaxing COVID-19 misinformation policies
By
Contributing Writer
July 26, 2022
Health
China just approved its first domestic anti-COVID pill, Azvudine, and is ready to produce 6.8 billion pills a year at half the price of Pfizer’s Paxlovid
By
Senior Editor
July 26, 2022
Health
Pfizer’s anti-COVID pill — used by Biden — is expected to rake in $23.2 billion, but confusion and weak demand could cause supply glut
By
Contributing Writer
July 25, 2022
Well
The Bill & Melinda Gates Foundation partly funded an Omicron variant study with a surprising conclusion about boosters
By
Research Team
July 21, 2022
Health
The U.S.’s woefully low COVID vaccination rate makes it Novavax’s most appealing market yet
By
Senior Editor
July 20, 2022
Health
CDC endorses Novavax COVID shot for adults, adding to the number of vaccine options
By
Lauran Neergaard
and
The Associated Press
July 19, 2022
Commentary
New viral threats are moving fast. Here’s how we can move faster
By
Crypto Correspondent
July 18, 2022
A ‘breadth of protection’: Novavax’s newly approved COVID vaccine arms the U.S. with a new weapon against Omicron BA.5 subvariant
By
Industry Analyst
July 14, 2022
Commentary
COVID finally got me. Will it come for you?
By
Investment Desk
July 12, 2022
Health
An Omicron vaccine is coming. Should you wait for it—or get your next booster now amid BA.5’s surge?
By
Industry Analyst
July 12, 2022
Health
New Omicron subvariants are causing COVID rates to increase. These are the states where it’s most contagious right now
By
Blockchain Reporter
July 11, 2022
Commentary
Why remote work will win this fall
By
Investment Desk
July 11, 2022
Beijing imposes China’s first-ever vaccine mandate as the new, highly transmissible Omicron variant tests its COVID-zero defenses
By
Research Team
July 7, 2022
Health
‘We will never be fully vaccinated against COVID’: Canadians may be required to get booster shot every 9 months
By
Staff Writer
July 5, 2022
Newsletters
Trust is fundamental to rethinking business’s role in society
By
David Meyer
and
Alan Murray
June 28, 2022
Most Popular
AI
Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
By
Contributing Writer
Economy
One of the world’s most popular economists on why AI is ‘undoubtedly going to crash’: It’s built off ‘digital...
By
Digital Assets Editor
Economy
Trump's retreats on tariffs have already wiped out $800 billion of expected deficit reduction, CBO estimates
By
News Correspondent